Clinicopathological features of senile systemic amyloidosis: An ante-and post-mortem study

Modern Pathology

Volumn 24, Issue 12, 2011, Pages 1533-1544

  Ueda, Mitsuharu ^a   Horibata, Yoko ^a   Shono, Makoto ^a   Misumi, Yohei ^a   Oshima, Toshinori ^a   Su, Yu ^a   Tasaki, Masayoshi ^a   Shinriki, Satoru ^a   Kawahara, Satomi ^a   Jono, Hirofumi ^a   Obayashi, Konen ^a   Ogawa, Hisao ^a   Ando, Yukio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

aging; amyloidosis; biopsy; diagnosis; familial amyloidotic polyneuropathy; senile systemic amyloidosis; transthyretin

Indexed keywords

AMYLOID; PREALBUMIN;

AGED; AGING; AMYLOIDOSIS; ARTICLE; AUTOPSY; BIOPSY; CAUSE OF DEATH; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; GASTROINTESTINAL TRACT; HEART VENTRICLE WALL; HEART WEIGHT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPANESE; MALE; PERICARDIUM; PRIORITY JOURNAL; SENILE AMYLOIDOSIS; SUBCUTANEOUS TISSUE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AMYLOID; AMYLOID NEUROPATHIES, FAMILIAL; AMYLOIDOSIS; AUTOPSY; BIOPSY; CARDIOMYOPATHIES; DNA MUTATIONAL ANALYSIS; FEMALE; GASTROINTESTINAL TRACT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; MYOCARDIUM; PHENOTYPE; PREALBUMIN; PREDICTIVE VALUE OF TESTS; SUBCUTANEOUS TISSUE;

EID: 82555165024     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.117     Document Type: Article

References (24)

1. Merlini G, Westermark P. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med 2004;255:159-178. (Pubitemid 38241361)
2. Benson MD. Amyloidosis. In: Koopman WJ (ed). Arthritis and Allied Conditions, A Textbook of Rheumatology, 14th edn. Lippincott Williams and Wilkins: Philadelphia, 2001, pp 1866-1895.
3. Cummings JL. Toward a molecular neuropsychiatry of neurodegenerative diseases. Ann Neurol 2003;54: 147-154. (Pubitemid 36909613)
4. Sipe JD, Benson MD, Buxbaum JN, et al. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 2010;17:101-104.
5. Westermark P, Bergström J, Solomon A, et al. Trans-thyretin-derived senile systemic amyloidosis: clinico-pathologic and structural considerations. Amyloid 2003;10:48-54. (Pubitemid 37372567)
6. Rapezzi C, Quarta CC, Riva L, et al. Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol 2010;7:398-408.
7. Cornwell III GG, Murdoch WL, Kyle RA, et al. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983;75:618-623. (Pubitemid 13012155)
8. Westermark P, Johansson B, Natvig JB. Senile cardiac amyloidosis: evidence of two different amyloid substances in the ageing heart. Scand J Immunol 1979;10:303-308. (Pubitemid 10196246)
9. Tanskanen M, Peuralinna T, Polvikoski T, et al. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglo-bulin and tau: a population-based autopsy study. Ann Med 2008;40:232-239. (Pubitemid 351482541)
10. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62:1057-1062. (Pubitemid 41043725)
11. Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007;36:411-423. (Pubitemid 47512065)
12. Connors LH, Lim A, Prokaeva T, et al. Tabulation of human transthyretin variants, 2003. Amyloid 2003;10:160-185.
13. Jacobson DR, Pastore RD, Yaghoubian R, et al. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997;336:466-473. (Pubitemid 27074357)
14. Coelho T, Maia L, Martins A, et al. Tafamidis (Fx-1006A): a first-in-class disease-modifying therapy for transthyretin familial amyloid. Proceedings of the XII International Symposium on Amyloidosis, 18-21 April 2010; Rome, Italy. International Society of Amyloidosis: Rome, 2010.
15. Hammarström P, Schneider F, Kelly JW. Trans-suppression of misfolding in an amyloid disease. Science 2001;293:2459-2462. (Pubitemid 32917328)
16. Ueda M, Ando Y, Nakamura M, et al. FK506 inhibits murine AA amyloidosis. Possible involvement of T cells in amyloidogenesis. J Rheumatol 2006;33: 2260-2270. (Pubitemid 44749787)
17. Misumi Y, Ando Y, Ueda M, et al. Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy. J Pathol 2009;219:481-490.
18. Ueda M, Misumi Y, Mizuguchi M, et al. SELDI-TOF MS evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy. Clin Chem 2009;55:1223-1227.
19. Pitkänen P, Westermark P, Cornwell III GG. Senile systemic amyloidosis. Am J Pathol 1984;117:391-399. (Pubitemid 15182480)
20. Strege RJ, Saeger W, Linke RP. Diagnosis and immuno-histochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series. Virchows Arch 1998;433:19-27. (Pubitemid 28356472)
21. Bergström J, Gustavsson A, Hellman U, et al. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Pathol 2005;206:224-232. (Pubitemid 40754027)
22. Takahashi K, Yi S, Kimura Y, et al. Familial amyloi-dotic polyneuropathy type 1 in Kumamoto, Japan: a clinicopathologic, histochemical, immunohistochem-ical, and ultrastructural study. Hum Pathol 1991;22: 519-527.
23. Sueyoshi T, Ueda M, Jono H, et al. Wild-type transthyretin-derived amyloidosis in various ligaments and tendons. Hum Pathol; published online 18 February 2011 e-pub ahead of print.
24. Roden AC, Aubry MC, Zhang K, et al. Nodular senile pulmonary amyloidosis: a unique case confirmed by immunohistochemistry, mass spectro-metry, and genetic study. Hum Pathol 2010;41: 1040-1045.